MIMIC-3D is developing next-generation 3D tumor microenvironment models designed to more faithfully replicate the complexity of human cancer biology. Our platform recreates layered, living tumor ecosystems in the laboratory, enabling researchers to study how cancer behaves within realistic tissue environments rather than simplified cell cultures.

Current preclinical models present major limitations. Traditional 2D cultures fail to capture the structural and biological complexity of tumors, while animal models are costly, slow, and often poorly predictive of human responses. As a result, many promising therapies fail during clinical development despite encouraging early data.

MIMIC-3D addresses this gap by engineering advanced 3D tumor systems that integrate multiple tissue layers and cell types to better mimic the architecture and dynamics of real human tumors. These models allow researchers to introduce patient-derived cancer cells and study their behavior within a controlled yet physiologically relevant environment.

Our goal is to provide more predictive, scalable, and biologically meaningful platforms for drug discovery, therapeutic testing, and translational oncology research. By enabling more accurate evaluation of drug responses earlier in the development process, MIMIC-3D aims to help accelerate the discovery of effective cancer treatments while reducing reliance on animal testing.

Founded by a multidisciplinary team spanning oncology research, biotechnology, and translational science, MIMIC-3D is building tools that bridge the gap between laboratory models and real human disease.

MIMIC-3D

Org chart

Teams

Offices

MIMIC-3D

Org chart

Teams

Offices

Related companies